This narrative review by Scanzello and Goldring examines the role of synovial inflammation in OA pathogenesis. It covers normal synovial function, histologic and imaging variability of OA synovitis, clinical associations with pain and structural progression, and the innate immune pathways that drive it. The central question: does synovitis cause OA symptoms and structural damage, or is it merely a bystander?
An OA patient with pain out of proportion to their X-ray grade is a pattern every orthopedic trainee will encounter. This review establishes why: synovitis is present in pre-radiographic knees, independently predicts pain severity, and nearly triples short-term cartilage progression risk.
When you see that patient — KL grade 2, significant pain, possible effusion on MRI. Consider active synovitis as a treatable driver rather than attributing everything to mechanical wear. Anti-inflammatory strategies (intra-articular steroids, targeted biologics under investigation) have a mechanistic rationale here beyond simple symptom management.
The histologic subtype also matters clinically. The inflammatory subtype occurs equally in early and late OA regardless of debris burden, meaning synovitis in a young patient after a meniscal tear is not just a reaction to cartilage fragments. It reflects genuine innate immune activation that may accelerate joint deterioration.
The TLR and complement pathways identified here have since become the basis for novel OA therapeutic targets, linking basic science directly to the next generation of disease-modifying treatments.
This narrative review by Scanzello and Goldring examines the role of synovial inflammation in OA pathogenesis. It covers normal synovial function, histologic and imaging variability of OA synovitis, clinical associations with pain and structural progression, and the innate immune pathways that drive it. The central question: does synovitis cause OA symptoms and structural damage, or is it merely a bystander?
An OA patient with pain out of proportion to their X-ray grade is a pattern every orthopedic trainee will encounter. This review establishes why: synovitis is present in pre-radiographic knees, independently predicts pain severity, and nearly triples short-term cartilage progression risk.
When you see that patient — KL grade 2, significant pain, possible effusion on MRI. Consider active synovitis as a treatable driver rather than attributing everything to mechanical wear. Anti-inflammatory strategies (intra-articular steroids, targeted biologics under investigation) have a mechanistic rationale here beyond simple symptom management.
The histologic subtype also matters clinically. The inflammatory subtype occurs equally in early and late OA regardless of debris burden, meaning synovitis in a young patient after a meniscal tear is not just a reaction to cartilage fragments. It reflects genuine innate immune activation that may accelerate joint deterioration.
The TLR and complement pathways identified here have since become the basis for novel OA therapeutic targets, linking basic science directly to the next generation of disease-modifying treatments.